Results 151 to 160 of about 6,150,654 (190)

Papillary renal neoplasm with reverse polarity: a novel entity for the next WHO classification? a clinical-pathological and molecular study of 15 cases, compared to eosinophilic/oncocytic papillary renal cell carcinoma. [PDF]

Virchows Arch
Marletta S, Fiorini D, Caliò A, Marcolini L, Stefanizzi L, Giacometti C, Pedron S, Vicentini C, Martignoni G.   +8 more
europepmc   +1 more source

Unanticipated papillary renal cell carcinoma in a complicated renal cyst: A case of radical nephrectomy following surgical complications. [PDF]

Urol Case Rep
Djafari AA, Hojjati SA, Rakhshan A, Hosseini T, Samenezhad S.   +4 more
europepmc   +1 more source

Exploiting NRF2-ARE pathway activation in papillary renal cell carcinoma. [PDF]

Int J Cancer
Angori S, Lakshminarayanan H, Banaei-Esfahani A, Mühlbauer K, Bolck HA, Kallioniemi O, Pietiäinen V, Schraml P, Moch H.   +8 more
europepmc   +1 more source

Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary renal cell carcinoma. [PDF]

Oncologist
De Vries-Brilland M, Hamilou Z, Ghosh S, Heng DYC, Wood LA, Basappa NS, Kollmannsberger CK, Graham J, Bhindi B, Finelli A, Bjarnason GA, Bosse D, Pouliot F, Castonguay V, Breau RH, Saleh RR, Winquist E, Lalani AA, Soulières D.   +18 more
europepmc   +1 more source

TPX2 promotes papillary renal cell carcinoma progression by forming a ceRNA with LINC00894. [PDF]

BMC Med Genomics
Ding Z, Ying W, Yan Y, Zhao Y, Liu C, Ma L.   +5 more
europepmc   +1 more source

Diagnostic challenges in infected cystic papillary renal cell carcinoma following recent right limited hemicolectomy. [PDF]

J Surg Case Rep
Farraj H, Al-Saa'd AA.
europepmc   +1 more source

Metabolic heterogeneity and survival outcomes in papillary renal cell carcinoma: insights from multi-datasets and machine learning analyses. [PDF]

Hereditas
Hu J, Liu YH, Xu GL, Zhang KQ.
europepmc   +1 more source

Combination of MLo-1508 with sunitinib for the experimental treatment of papillary renal cell carcinoma. [PDF]

Front Oncol
Marques-Magalhães Â, Moreira-Silva F, Graça I, Dias PC, Correia MP, Alzamora MA, Henrique R, Lopez M, Arimondo PB, Miranda-Gonçalves V, Jerónimo C.   +10 more
europepmc   +1 more source

TRIM59 suppresses mitochondrial-associated apoptosis to facilitate progression in papillary renal cell carcinoma via the ACAT1-cardiolipin pathway. [PDF]

Cell Death Dis
Weng H, Zhong J, Yang R, Han B, Kong Q, Zhang Y, Zhuang W, Wang J, Hu H, Lin X.   +9 more
europepmc   +1 more source